Gadin Injection (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 56mg
Injections · Prescription medication
Unimed Pharmaceuticals Co., Ltd.
MFDS item code 199102954 · Notified 1991.11.08
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers) and upper gastrointestinal bleeding; prevention of Mendelson syndrome
This medication is effective in treating gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and is used for ulcer treatment after surgery. Additionally, it helps in the treatment of upper gastrointestinal bleeding, acute stress ulcers, and acute gastric mucosal lesions. It acts safely and effectively on various gastrointestinal-related diseases, improving patients' symptoms.
Administer 50mg of ranitidine intravenously or intramuscularly 3-4 times daily. For intravenous injection, dilute 50mg of this drug in 20ml of normal saline injection or dextrose injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous drip over 2 hours at a rate of 25mg/hr. For upper gastrointestinal bleeding, an effect is generally seen within 1 week; switch to oral administration when oral dosing becomes possible. For preanesthetic medication (prevention of Mendelson's syndrome), administer 50mg intramuscularly or inject slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. For patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Clinical studies in children have not been established.
This medication should not be administered to patients with hypersensitivity to its components. Patients with impaired renal function may experience prolonged retention of this medication in the body, which can increase the risk of side effects; therefore, use caution by reducing the dosage or extending the administration interval. Caution is also needed for patients with impaired liver function, those with a history of drug hypersensitivity, and elderly patients. Patients with a rare history of acute porphyria should not use this medication. This medication may rarely cause serious allergic reactions, Blood abnormalities, liver dysfunction, cardiac problems, gastrointestinal symptoms, neurological anomalies, skin rashes, etc. If any abnormal symptoms occur, discontinue administration immediately and inform a healthcare provider. During treatment, regular blood tests, liver function tests, and renal function tests should be performed to monitor for abnormalities. Elderly patients or those with chronic pulmonary diseases, diabetes, or weakened immune systems should be cautious as they may have an increased risk of pneumonia. If high doses of this medication are administered intravenously for more than 5 days, liver enzyme levels may rise, and daily liver function tests are recommended. If oral administration is possible, it is advisable to switch to an oral form; this medication should only be used when oral administration is difficult. This medication may interact with other drugs, necessitating dosage adjustment or discontinuation of concomitant medications; therefore, it's essential to inform healthcare providers of any medications currently being taken. Pregnant women or those who might become pregnant and nursing mothers should only use this medication cautiously if necessary. The safety of this medication in pediatric patients has not been adequately established, so caution is advised for use. This medication may affect the results of certain clinical tests; thus, it is important to inform healthcare professionals during testing. In the event of overdose, emergency measures such as inducing vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be required. Administration via injection may cause pain or induration at the injection site, and in patients at risk of abnormal heart rate, the infusion should be done slowly. This medication can mask symptoms of stomach cancer; therefore, gastric ulcer patients or those experiencing new or worsening dyspeptic symptoms in middle age should have malignancy ruled out before administration. Regular eye examinations are recommended to check eye health during long-term administration.
Anaphylactic shock, urticaria, angioedema, rash, fever, bronchospasm, hypotension, chest pain, vascular edema, granulocytopenia, elevated serum creatinine, leukopenia, thrombocytopenia, hypoplasia of bone marrow, aplastic anemia, aplastic anemia, pure red cell aplasia, hypereosinophilia, liver dysfunction, jaundice, hepatitis, bradycardia, heart block, tachycardia, vasculitis, cardiac arrest, constipation, nausea, vomiting, abdominal distension, abdominal pain, loss of appetite, diarrhea, acute pancreatitis, dizziness, drowsiness, seizures, headache, heaviness in the head, insomnia, agitation, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorders, altered consciousness, hepatic myoclonus, gynecomastia, excessive milk secretion, erectile dysfunction, decreased libido, arthralgia, myalgia, rhabdomyolysis, skin rash, erythema multiforme, alopecia, stomatitis, pruritus, acute interstitial nephritis, pain at the site of intramuscular injection, induration at the site of intramuscular injection.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and light. It is advisable to keep it at room temperature and avoid direct sunlight. Proper storage helps maintain the medication's efficacy.
An ampoule containing a light yellow transparent solution
50 ampoules
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 56mg
Injections · Prescription medication
Unimed Pharmaceuticals Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.